OBJECTIVE: Chronic kidney disease (CKD) is a serious disorder with significant public health impact. Identification of factors associated with risk of progression of kidney disease may help in earlier intervention in high-risk groups. We investigated whether brachial pulse pressure (PP) was associated with 5-year changes in estimated glomerular filtration rate (eGFR) and incident CKD and whether type 2 diabetes modified these associations. METHODS: In the population-based Australian Diabetes, Obesity and Lifestyle Study (AusDiab) 5554 individuals (5.8% with type 2 diabetes) who took part in the 5-year follow-up and had no CKD or microalbuminuria at baseline were included. RESULTS: After adjusting for baseline age, sex, eGFR and use of blood pressure-lowering medication, each baseline SD higher PP was associated with a decline in eGFR of 0.32 ml/min (P=0.006) and an odds ratio (OR) for CKD of 1.29 [95% confidence interval (CI) 1.09-1.53] in individuals without type 2 diabetes. In individuals with type 2 diabetes, eGFR declined by 1.10 ml/min (P=0.011) and the OR for incident CKD was 1.94 (1.14-3.29). Similar associations with eGFR decline were observed with systolic blood pressure and incident CKD in individuals without type 2 diabetes. In individuals with type 2 diabetes, higher systolic blood pressure was only significantly associated with eGFR decline if the diastolic blood pressure was 70 mmHg or less (P for interaction between systolic and diastolic blood pressure: 0.033). CONCLUSIONS: PP is an important risk factor for eGFR decline and incident CKD over a 5-year period, especially in individuals with type 2 diabetes.
OBJECTIVE:Chronic kidney disease (CKD) is a serious disorder with significant public health impact. Identification of factors associated with risk of progression of kidney disease may help in earlier intervention in high-risk groups. We investigated whether brachial pulse pressure (PP) was associated with 5-year changes in estimated glomerular filtration rate (eGFR) and incident CKD and whether type 2 diabetes modified these associations. METHODS: In the population-based Australian Diabetes, Obesity and Lifestyle Study (AusDiab) 5554 individuals (5.8% with type 2 diabetes) who took part in the 5-year follow-up and had no CKD or microalbuminuria at baseline were included. RESULTS: After adjusting for baseline age, sex, eGFR and use of blood pressure-lowering medication, each baseline SD higher PP was associated with a decline in eGFR of 0.32 ml/min (P=0.006) and an odds ratio (OR) for CKD of 1.29 [95% confidence interval (CI) 1.09-1.53] in individuals without type 2 diabetes. In individuals with type 2 diabetes, eGFR declined by 1.10 ml/min (P=0.011) and the OR for incident CKD was 1.94 (1.14-3.29). Similar associations with eGFR decline were observed with systolic blood pressure and incident CKD in individuals without type 2 diabetes. In individuals with type 2 diabetes, higher systolic blood pressure was only significantly associated with eGFR decline if the diastolic blood pressure was 70 mmHg or less (P for interaction between systolic and diastolic blood pressure: 0.033). CONCLUSIONS: PP is an important risk factor for eGFR decline and incident CKD over a 5-year period, especially in individuals with type 2 diabetes.
Authors: Robert J Anderson; Gideon D Bahn; Nicholas V Emanuele; Jennifer B Marks; William C Duckworth Journal: Diabetes Care Date: 2014-07-21 Impact factor: 19.112
Authors: K P Ng; W E Moody; C D Chue; N C Edwards; T Savage; C R V Tomson; R P Steeds; J N Townend; C J Ferro Journal: J Hum Hypertens Date: 2013-08-01 Impact factor: 3.012
Authors: Mohammed Al Za'abi; Mahfouda Al Busaidi; Javid Yasin; Nicole Schupp; Abderrahim Nemmar; Badreldin H Ali Journal: Am J Transl Res Date: 2015-01-15 Impact factor: 4.060
Authors: Jong Ho Kim; Sang Soo Kim; In Joo Kim; Bo Hyun Kim; Ja Young Park; Chang Won Lee; Ji Hye Suk; Sun Hae Shin; Sung Pyo Son; Min Chul Kim; Jun Hyeob Ahn; Kwang Jae Lee; Min Jung Kwon; Soon Hee Lee; Jeong Hyun Park Journal: J Diabetes Res Date: 2017-08-16 Impact factor: 4.011